Delivery Order SPE2DB22D3011-SPE2DB25FQ2SB
- Not listed
- The Defense Logistics Agency awarded a $10,028.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 9, 2025, with completion expected by September 10, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials valued at $3,070.80, with an ultimate completion date of August 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,692.64 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract with performance to be conducted in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $2,615.98 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $8,241.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.40 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,104.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. This competitively awarded, firm fixed-price contract was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, valued at $1,577.68, represents a competitively awarded contract with an ultimate completion date of July 22, 2025. The award was issued without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2SBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,651.78 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials on September 11, 2025, with completion scheduled for September 12, 2025. This competitive delivery order utilizes firm fixed pricing and is performed at the contractor's headquarters in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and its Medical Supply Chain, delivering a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a for-profit organization registered in the System for Award Management, AmerisourceBergen demonstrates capability to meet federal procurement requirements through open competition, with this particular delivery order requiring no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/11/25 |